Wealthspire Advisors (Maryland)’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-289
Closed -$16K 1158
2019
Q1
$16K Sell
289
-80
-22% -$4.07K ﹤0.01% 1360
2018
Q4
$17K Sell
369
-60
-14% -$3.29K ﹤0.01% 1264
2018
Q3
$28K Sell
429
-182
-30% -$11.3K ﹤0.01% 1176
2018
Q2
$39K Sell
611
-253
-29% -$15.7K ﹤0.01% 1071
2018
Q1
$48K Hold
864
﹤0.01% 1003
2017
Q4
$41K Sell
864
-322
-27% -$15.8K ﹤0.01% 1082
2017
Q3
$60K Sell
1,186
-39
-3% -$2K 0.01% 901
2017
Q2
$67K Buy
1,225
+126
+11% +$6.02K 0.01% 839
2017
Q1
$46K Buy
1,099
+315
+40% +$13.5K 0.01% 825
2016
Q4
$34K Buy
784
+34
+5% +$1.38K 0.01% 868
2016
Q3
$31K Sell
750
-804
-52% -$33.7K ﹤0.01% 917
2016
Q2
$62K Buy
1,554
+686
+79% +$24.7K 0.01% 673
2016
Q1
$29K Sell
868
-268
-24% -$8.35K 0.01% 848
2015
Q4
$38K Buy
+1,136
New +$35.5K 0.01% 790

Other funds holding IART

Wealthspire Advisors (Maryland)'s IART Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Integra LifeSciences (IART) in Q2 2019, closing a stake of 289 shares — an estimated $16K sold.

Wealthspire Advisors (Maryland) first reported a position in IART in Q4 2015 and held it in 14 quarters. The position peaked at $67K in Q2 2017. 262 funds tracked by Wall St. Rank hold IART as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Integra LifeSciences position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 289 Integra LifeSciences shares in Q2 2019, an estimated $16K.
  • Wealthspire Advisors (Maryland) first reported a position in Integra LifeSciences in Q4 2015 and held it in 14 quarters.
  • Wealthspire Advisors (Maryland)'s Integra LifeSciences position peaked at $67K in Q2 2017.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.